Franklin Resources, Inc. 13D and 13G filings for EyePoint Pharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-01-27 12:58 pm Purchase | 2024-12-31 | 13G | EyePoint Pharmaceuticals, Inc. EYPT | FRANKLIN RESOURCES INC BEN | 4,137,567 6.100% | 125,519 (+3.13%) | Filing |
| 2024-10-31 12:51 pm Sale | 2024-09-30 | 13G | EyePoint Pharmaceuticals, Inc. EYPT | FRANKLIN RESOURCES INC BEN | 4,012,048 7.500% | -628,603 (-13.55%) | Filing |
| 2024-02-06 10:55 am Purchase | 2023-12-31 | 13G | EyePoint Pharmaceuticals, Inc. EYPT | FRANKLIN RESOURCES INC BEN | 4,640,651 9.500% | 510,514 (+12.36%) | Filing |
| 2023-09-11 11:15 am Sale | 2023-08-31 | 13G | EyePoint Pharmaceuticals, Inc. EYPT | FRANKLIN RESOURCES INC BEN | 4,130,137 11.800% | -1,644,372 (-28.48%) | Filing |
| 2023-01-31 11:44 am Purchase | 2022-12-31 | 13G | EyePoint Pharmaceuticals, Inc. EYPT | FRANKLIN RESOURCES INC BEN | 5,774,509 16.900% | 827,344 (+16.72%) | Filing |
| 2022-02-03 2:02 pm Purchase | 2021-12-31 | 13G | EyePoint Pharmaceuticals, Inc. EYPT | FRANKLIN RESOURCES INC BEN | 4,947,165 14.600% | 3,533,218 (+249.88%) | Filing |
| 2021-02-01 2:18 pm Purchase | 2020-12-31 | 13G | EyePoint Pharmaceuticals, Inc. EYPT | FRANKLIN RESOURCES INC BEN | 1,413,947 7.800% | 1,413,947 (New Position) | Filing |